Cargando…

Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization

Activating droplets vaporization has become an attractive strategy for ultrasound imaging and physical therapy due to the significant increase in ultrasound backscatter signals and its ability to physically damage the tumor cells. However, the current two types of transitional droplets named after t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ronghui, Zhou, Yang, Zhang, Ping, Chen, Yu, Gao, Wei, Xu, Jinshun, Chen, Hangrong, Cai, Xiaojun, Zhang, Kun, Li, Pan, Wang, Zhigang, Hu, Bing, Ying, Tao, Zheng, Yuanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381248/
https://www.ncbi.nlm.nih.gov/pubmed/28382158
http://dx.doi.org/10.7150/thno.17251
_version_ 1782519902152687616
author Wang, Ronghui
Zhou, Yang
Zhang, Ping
Chen, Yu
Gao, Wei
Xu, Jinshun
Chen, Hangrong
Cai, Xiaojun
Zhang, Kun
Li, Pan
Wang, Zhigang
Hu, Bing
Ying, Tao
Zheng, Yuanyi
author_facet Wang, Ronghui
Zhou, Yang
Zhang, Ping
Chen, Yu
Gao, Wei
Xu, Jinshun
Chen, Hangrong
Cai, Xiaojun
Zhang, Kun
Li, Pan
Wang, Zhigang
Hu, Bing
Ying, Tao
Zheng, Yuanyi
author_sort Wang, Ronghui
collection PubMed
description Activating droplets vaporization has become an attractive strategy for ultrasound imaging and physical therapy due to the significant increase in ultrasound backscatter signals and its ability to physically damage the tumor cells. However, the current two types of transitional droplets named after their activation methods have their respective limitations. To circumvent the limitations of these activation methods, here we report the concept of magnetic droplet vaporization (MDV) for stimuli-responsive cancer theranostics by a magnetic-responsive phase-transitional agent. This magnetic-sensitive phase-transitional agent—perfluorohexane (PFH)-loaded porous magnetic microspheres (PFH-PMMs), with high magnetic-thermal energy-transfer capability, could quickly respond to external alternating current (AC) magnetic fields to produce thermal energy and trigger the vaporization of the liquid PFH. We systematically demonstrated MDV both in vitro and in vivo. This novel trigger method with deep penetration can penetrate the air-filled viscera and trigger the vaporization of the phase-transitional agent without the need of pre-focusing lesion. This unique MDV strategy is expected to substantially broaden the biomedical applications of nanotechnology and promote the clinical treatment of tumors that are not responsive to chemical therapies.
format Online
Article
Text
id pubmed-5381248
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-53812482017-04-05 Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization Wang, Ronghui Zhou, Yang Zhang, Ping Chen, Yu Gao, Wei Xu, Jinshun Chen, Hangrong Cai, Xiaojun Zhang, Kun Li, Pan Wang, Zhigang Hu, Bing Ying, Tao Zheng, Yuanyi Theranostics Research Paper Activating droplets vaporization has become an attractive strategy for ultrasound imaging and physical therapy due to the significant increase in ultrasound backscatter signals and its ability to physically damage the tumor cells. However, the current two types of transitional droplets named after their activation methods have their respective limitations. To circumvent the limitations of these activation methods, here we report the concept of magnetic droplet vaporization (MDV) for stimuli-responsive cancer theranostics by a magnetic-responsive phase-transitional agent. This magnetic-sensitive phase-transitional agent—perfluorohexane (PFH)-loaded porous magnetic microspheres (PFH-PMMs), with high magnetic-thermal energy-transfer capability, could quickly respond to external alternating current (AC) magnetic fields to produce thermal energy and trigger the vaporization of the liquid PFH. We systematically demonstrated MDV both in vitro and in vivo. This novel trigger method with deep penetration can penetrate the air-filled viscera and trigger the vaporization of the phase-transitional agent without the need of pre-focusing lesion. This unique MDV strategy is expected to substantially broaden the biomedical applications of nanotechnology and promote the clinical treatment of tumors that are not responsive to chemical therapies. Ivyspring International Publisher 2017-02-08 /pmc/articles/PMC5381248/ /pubmed/28382158 http://dx.doi.org/10.7150/thno.17251 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Wang, Ronghui
Zhou, Yang
Zhang, Ping
Chen, Yu
Gao, Wei
Xu, Jinshun
Chen, Hangrong
Cai, Xiaojun
Zhang, Kun
Li, Pan
Wang, Zhigang
Hu, Bing
Ying, Tao
Zheng, Yuanyi
Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization
title Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization
title_full Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization
title_fullStr Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization
title_full_unstemmed Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization
title_short Phase-transitional Fe(3)O(4)/perfluorohexane Microspheres for Magnetic Droplet Vaporization
title_sort phase-transitional fe(3)o(4)/perfluorohexane microspheres for magnetic droplet vaporization
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381248/
https://www.ncbi.nlm.nih.gov/pubmed/28382158
http://dx.doi.org/10.7150/thno.17251
work_keys_str_mv AT wangronghui phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT zhouyang phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT zhangping phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT chenyu phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT gaowei phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT xujinshun phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT chenhangrong phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT caixiaojun phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT zhangkun phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT lipan phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT wangzhigang phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT hubing phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT yingtao phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization
AT zhengyuanyi phasetransitionalfe3o4perfluorohexanemicrospheresformagneticdropletvaporization